Cardinal Health, Inc.

CAH

US14149Y1082

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2024-04-19 pm EDT			5-day change	1st Jan Change
108.2 ^USD	+2.07%		+1.08%	+7.33%

Apr. 17	AdaptHealth Names Suzanne Foster CEO	DJ
Apr. 02	Cardinal Health Announces Location of Pharmaceutical Distribution Center for Over-The-Counter Products	CI

Cardinal Health, Inc.(NYSE:CAH) added to Russell 3000E Value Index

June 25, 2021 at 12:00 am EDT

Latest news about Cardinal Health, Inc.

AdaptHealth Names Suzanne Foster CEO	Apr. 17	DJ
Cardinal Health Announces Location of Pharmaceutical Distribution Center for Over-The-Counter Products	Apr. 02	CI
Cardinal Health Gains Approval for Science-Based Targets to Cut Greenhouse Gas Emissions	Mar. 15	MT
Transcript : Cardinal Health, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 08:30 AM	Mar. 13
Cardinal Health, Inc. Elects Robert "Bob" Azelby as Independent Director, Effective March 1, 2024	Feb. 28	CI
Leerink Partners Starts Cardinal Health With Outperform Rating, $125 Price Target	Feb. 26	MT
US FTC, DHHS Request Information on Shortages of Generic Drugs; McKesson Shares Ease	Feb. 14	MT
Binx health, inc. Enters into National Distribution Agreement with Cardinal Health to Increase Access to the CLIA-Waived, FDA-Cleared binx io	Feb. 12	CI
North American Morning Briefing : Stock Futures -2-	Feb. 12	DJ
Argus Upgrades Cardinal Health to Buy From Hold, Price Target is $120	Feb. 09	MT
Cardinal Health Keeps Quarterly Dividend at $0.5006 a Share, Payable April 15 to Shareholders of Record April 1	Feb. 06	MT
Cardinal Health Approves Quarterly Dividend, Payable on April 15, 2024	Feb. 06	CI
Precipio, Inc. and Cardinal Health Sign Distribution Agreement for Its HemeScreen®? Portfolio of Molecular Assays for Cancer	Feb. 06	CI
UBS Adjusts Cardinal Health Price Target to $125 From $122, Maintains Buy Rating	Feb. 05	MT
Tranche Update on Cardinal Health, Inc.'s Equity Buyback Plan announced on June 8, 2023.	Feb. 01	CI
Tranche Update on Cardinal Health, Inc.'s Equity Buyback Plan announced on November 9, 2021.	Feb. 01	CI
Cardinal Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 01	CI
Cardinal Health Seeks M&A	Feb. 01	CI
Transcript : Cardinal Health, Inc., Q2 2024 Earnings Call, Feb 01, 2024	Feb. 01
Cardinal Health's Fiscal Q2 Adjusted Earnings, Revenue Rise; Raises 2024 Guidance	Feb. 01	MT
Earnings Flash (CAH) CARDINAL HEALTH Posts Q2 Revenue $57.45B, vs. Street Est of $56.91B	Feb. 01	MT
Earnings Flash (CAH) CARDINAL HEALTH Reports Q2 EPS $1.82, vs. Street Est of $1.60	Feb. 01	MT
North American Morning Briefing : Stock Futures -2-	Feb. 01	DJ
News Highlights : Top Company News of the Day - Wednesday at 3 PM ET	Jan. 31	DJ
Cardinal Health Buying Specialty Networks for $1.2 Billion in Cash to Build Analytics Offerings	Jan. 31	MT

Cardinal Health, Inc. is specialized in the distribution of products and health services to pharmacies, hospitals and medical practices. Net sales break down by activity as follows: - distribution of pharmaceutical products (92.7%); - distribution of medical, surgical and laboratory products (7.3%). The group also develops a manufacturing of medical and surgical products activity (masks, overalls, gloves, diagnostic products, products of aspiration and collection of liquids, radiology intervention, respiratory assistance, etc.). The United States accounts for 97.7% of net sales.

Sector

Pharmaceuticals

Calendar

2024-05-01 - Q3 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Cardinal Health, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

106 USD

Average target price

113.9 USD

Spread / Average Target

+7.42%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
CARDINAL HEALTH, INC.	+7.33%	25.78B
MCKESSON CORPORATION	+13.36%	68.18B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+6.34%	7.99B
SINOPHARM GROUP CO. LTD.	-2.79%	7.88B
HUADONG MEDICINE CO., LTD	-24.02%	7.62B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+21.83%	4.45B
EBOS GROUP LIMITED	-2.28%	3.89B
GALENICA AG	-3.51%	3.82B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+25.02%	3.69B
MEDIPAL HOLDINGS CORPORATION	+3.28%	3.24B

Pharmaceuticals Wholesale